Wenche Sjursen

Summary

Affiliation: St. Olavs Hospital
Country: Norway

Publications

  1. ncbi request reprint Mutation screening in a Norwegian cohort with pheochromocytoma
    Wenche Sjursen
    Departments of Pathology and Medical Genetics, St Olav University Hospital, NO 7006, Trondheim, Norway
    Fam Cancer 12:529-35. 2013
  2. doi request reprint A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts
    Wenche Sjursen
    Department of Pathology and Medical Genetics, St Olavs University Hospital, Erling Skjalgssons gt 1, 7006 Trondheim, Norway
    Fam Cancer 8:179-86. 2009
  3. pmc Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers
    Wenche Sjursen
    Department of Pathology and Medical Genetics, St Olavs University Hospital, Trondheim, Norway
    J Med Genet 47:579-85. 2010

Detail Information

Publications3

  1. ncbi request reprint Mutation screening in a Norwegian cohort with pheochromocytoma
    Wenche Sjursen
    Departments of Pathology and Medical Genetics, St Olav University Hospital, NO 7006, Trondheim, Norway
    Fam Cancer 12:529-35. 2013
    ..Two new NF1 variants and one new VHL gene variant were detected...
  2. doi request reprint A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts
    Wenche Sjursen
    Department of Pathology and Medical Genetics, St Olavs University Hospital, Erling Skjalgssons gt 1, 7006 Trondheim, Norway
    Fam Cancer 8:179-86. 2009
    ..cDNA analysis showed that the homozygous mutation led to two abnormal transcripts, of which one is perhaps less detrimental. Thus cDNA analysis is of prime importance for the full evaluation of the effect of putative splicing mutations...
  3. pmc Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers
    Wenche Sjursen
    Department of Pathology and Medical Genetics, St Olavs University Hospital, Trondheim, Norway
    J Med Genet 47:579-85. 2010
    ..The authors have previously reported that clinical criteria are not sensitive enough to identify MMR mutation carriers among incident colorectal cancer cases...